Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Arcoleo F"'
Autor:
Aberer, W., Grumach, A., Bygum, A., Blanchard Delaunay, C., Bouillet, L., Coppere, B., Fain, O., Goichot, B., Gompel, A., Guez, S., Jeandel, P., Kanny, G., Launay, D., Maillard, H., Martin, L., Masseau, A., Ollivier, Y., Sobel, A., Arnolds, J., Aygören-Pürsün, E., Baş, M., Bauer, A., Bork, K., Martinez, I., Maurer, M., Papadopoulou-Alataki, E., Psarros, F., Graif, Y., Kivity, S., Reshef, A., Toubi, E., Arcoleo, F., Cicardi, M., Manconi, P., Marone, G., Montinaro, V., Baeza, M.L., Caballero, T., Cabañas, R., Guilarte, M., Hernandez de Rojas, D., Hernando de Larramendi, C., Lleonart, R., Lobera, T., Sáenz de San Pedro, B., Bjorkander, J., Helbert, M., Longhurst, H.J., Zanichelli, Andrea, Longhurst, Hilary J., Maurer, Marcus, Bouillet, Laurence, Aberer, Werner, Fabien, Vincent, Andresen, Irmgard, Caballero, Teresa
Publikováno v:
In Annals of Allergy, Asthma & Immunology October 2016 117(4):394-398
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zanichelli, A., Maurer, M., Aberer, W., Caballero, T., Longhurst, H. J., Bouillet, L., Fabien, V., Andresen, I., Grumach, A., Bygum, A., Blanchard Delaunay, C., Boccon-Gibod, I., Coppere, B., Du Thanh, A., Dzviga, C., Fain, O., Goichot, B., Gompel, A., Guez, S., Jeandel, P., Kanny, G., Launay, D., Maillard, H., Martin, L., Masseau, A., Ollivier, Y., Sobel, A., Aygören-Pürsün, E., Bas, M., Bauer, A., Bork, K., Greve, J., Magerl, M., Martinez Saguer, I., Strassen, U., Papadopoulou-Alataki, E., Psarros, F., Graif, Y., Kivity, S., Reshef, A., Toubi, E., Arcoleo, F., Bova, M., Cicardi, M., Manconi, P., Marone, G., Montinaro, V., Triggiani, M., Baeza, L., Cabañas, R., Gala Ortiz, G., Guilarte, M., Hernandez, D., Hernando de Larramendi, C., Lleonart, R., Lobera, T., Marques, L., Saenz de San Pedro, B., Björkander, J., Bethune, C., Garcez, T.
Publikováno v:
Allergy
Zanichelli, A, Maurer, M, Aberer, W, Caballero, T, Longhurst, H J, Bouillet, L, Fabien, V, Andresen, I, IOS Study Group & Bygum, A 2017, ' Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 72, no. 6, pp. 994-998 . https://doi.org/10.1111/all.13103
Zanichelli, A, Maurer, M, Aberer, W, Caballero, T, Longhurst, H J, Bouillet, L, Fabien, V, Andresen, I, IOS Study Group & Bygum, A 2017, ' Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 72, no. 6, pp. 994-998 . https://doi.org/10.1111/all.13103
The Icatibant Outcome Survey (IOS) is an observational study monitoring safety and effectiveness of icatibant in the real‐world setting. We analyzed safety data from 3025 icatibant‐treated attacks in 557 patients (enrolled between July 2009 and F
Autor:
Bygum A, Caballero T, Grumach A, Longhurst H, Bouillet L, Aberer W, Zanichelli A, Botha J, Andresen I, Maurer M, Delaunay C, Boccon-Gibod I, Coppere B, Du Thanh A, Dzviga C, Fain O, Goichot B, Gompel A, Guez S, Jeandel P, Kanny G, Launay D, Maillard H, Martin L, Masseau A, Ollivier Y, Sobel A, Aygoren-Pursun E, Bas M, Bauer M, Bork K, Greve J, Magerl M, Martinez-Saguer I, Strassen U, Papadopoulou-Alataki E, Psarros F, Graff Y, Kivity S, Reshef A, Toubi E, Arcoleo F, Bova M, Cicardi M, Nconi P, Marone G, Montinaro V, Triggiani M, Baeza M, Cabanas R, Guilarte M, Hernandez D, de Larramendi C, Lleonart R, Lobera T, Marques L, Pedro B, Bjorkander J, Bethune C, Garcez T, IOS Study Grp
Publikováno v:
Clinical and Translational Allergy
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Background: Hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE) is characterized by recurrent swelling in subcutaneous or submucosal tissues. Symptoms often begin by age 5-11 years and worsen during puberty, but attacks can occur at any a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::116c39258371d5522a77d3dcf9b62c5b
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13100
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13100
Autor:
Aberer, Werner, Maurer, Marcus, Bouillet, Laurence, Zanichelli, Andrea, Caballero, Teresa, Longhurst, Hilary J., Perrin, Amandine, Andresen, Irmgard, Wiednig, M., Grumach, A., Bygum, A., Blanchard Delauny, C., Boccon-Gibod, I., Coppere, B., Fain, O., Goichot, B., Gompel, A., Guez, S., Jeandel, P. Y., Kanny, G., Launay, D., Maillard, H., Martin, L., Masseau, A., Ollivier, Y., Sobel, A., Arnolds, J., Aygören-Pürsün, E., Bas, M., Bauer, M., Bork, K., Magerl, M., Martinez-Saguer, I., Papadopoulou-Alataki, E., Psarros, F., Graif, Y., Kivity, S., Reshef, A., Toubi, E., Arcoleo, F., Bova, M., Cicardi, M., Manconi, P., Montinaro, V., Marone, G., Baeza, M. L., Cabañas, R., Guilarte, M., Hernandez, D., Hernando de Larramendi, C., Lleonart, R., Lobera, T., Marques, L., Saenz de San Pedro, B., Bjoerkander, J., Bethune, C., Garcez Pereira, T., Helbert, M.
Publikováno v:
Aberer, W, Maurer, M, Bouillet, L, Zanichelli, A, Caballero, T, Longhurst, H J, Perrin, A, Andresen, I, IOS Study Group & Bygum, A 2017, ' Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant : findings from the Icatibant Outcome Survey ', Allergy, Asthma, and Clinical Immunology, vol. 13, 31 . https://doi.org/10.1186/s13223-017-0203-z
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 13, Iss 1, Pp 1-9 (2017)
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 13, Iss 1, Pp 1-9 (2017)
BACKGROUND: Patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) experience recurrent attacks of cutaneous or submucosal edema that may be frequent and severe; prophylactic treatments can be prescribed to prevent atta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0817ef691e44eb18f3a8c5e44c8a789f
https://findresearcher.sdu.dk:8443/ws/files/125574874/Breakthrough_attacks_in_patients.pdf
https://findresearcher.sdu.dk:8443/ws/files/125574874/Breakthrough_attacks_in_patients.pdf
Autor:
Caballero, T., Aberer, W., Longhurst, H.J., Maurer, M., Zanichelli, A., Perrin, A., Bouillet, L., Andresen, I., Arcoleo, F., Bova, M., Cicardi, M., Cillari, E., Montinaro, V., Marone, G., Blanchard Delauny, C., Boccon‐Gibod, I., Coppere, B., Dzviga, C., Fain, O., Goichot, B., Gompel, A., Guez, S., Jeandel, P.Y., Kanny, G., Launay, D., Maillard, H., Martin, L., Masseau, A., Ollivier, Y., Magerl, M., Baeza, M.L., Cabañas, R., Guilarte, M., Hernández, D., Hernando de Larramendi, C., Lleonart, R., Lobera, T., Marqués, L., Bangs, C., Buckland, M., Grigoriadou, S., Helbert, M., Lorenzo, L.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
Background Hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) is a rare, potentially fatal, bradykinin-mediated disease. Icatibant is a bradykinin B2 receptor antagonist originally approved in 2008 in the European Union and 2011
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab80520f2ce9abcbedb798b9d27f0e1b
http://hdl.handle.net/11588/702401
http://hdl.handle.net/11588/702401
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maurer, Marcus, Longhurst, Hilary J., Fabien, Vincent, Li, H. Henry, Lumry, William R., Aberer, W., Bygum, A., Blanchard Delauny, C., Boccon Gibod, I., Bouillet, L., Fain, O., Gompel, A., Launay, D., Maillard, H., Ollivier, Y., Bork, K., Greve, J., Maurer, M., Psarros, F., Toubi, E., Arcoleo, F., Montinaro, V., Zanichelli, A., Caballero, M. T., Guilarte, M., Hernandez, D., Baeza, M. L., Helbert, M., Longhurst, H., BOVA, MARIA, MARONE, GIANNI
Publikováno v:
Allergy and asthma proceedings. 35(5)
Icatibant was efficacious and generally well tolerated for type I or II hereditary angioedema (HAE) attacks in adults in the phase III, randomized, placebo-controlled For Angioedema Subcutaneous Treatment (FAST)-3 trial. The Icatibant Outcome Survey
Autor:
Cancian, M, Arcoleo, F, Bafunno, V, Barca, Mp, Borrelli, P, Bova, M, Di Rocco PC, Cicardi, M, Cillari, E, De Carolis, C, De Pasquale, T, Del Corso, I, Guarino, Md, Massaro, I, Minale, P, Montinaro, V, Neri, S, Perricone, R, Pucci, S, Quattrocchi, P, Rossi, O, Senter, Riccardo, Triggiani, M, Zanichelli, A, Zanierato, G, Zoli, A.
Hereditary angioedema (HAE) due to C1-inhibitor (C1-INH) deficiency (C1-INH-HAE) is a rare disease, with a reported prevalence of about 1 : 50 000. C1-INH-HAE causes disabling symptoms, which may be life-threatening if swelling affects upper airways.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f437d2842a9cd44b02864bf142621c
http://hdl.handle.net/11386/4675144
http://hdl.handle.net/11386/4675144